Literature DB >> 15791475

Cervical adult rhabdomyoma presenting as a rapidly growing mass in a patient with diffuse large B-cell non-Hodgkin's lymphoma.

T Hansen1, J E Burg, D Koutsimpelas, W J Mann, C J Kirkpatrick.   

Abstract

BACKGROUND: Adult rhabdomyoma is a rare mesenchymal tumor, which generally grows slowly and is mainly localized in the head and neck area. PATIENT AND METHODS: We report the extraordinary case of a rapidly growing adult rhabdomyoma in a 73-year-old man. The patient was treated for diffuse large B-cell non-Hodgkin's lymphoma with CHOP therapy (doxorubicin, cyclophosphamide, vincristine, and prednisone). Comparison of the respective computed tomography scans showed prominent enlargement of 35% in the tumor mass volume on the right side of the neck within 3 months. The tumor was highly suspicious for lymphoma. Surgical resection was performed.
RESULTS: Histological examination revealed a tumor which was composed of tightly packed polygonal cells with a PAS-positive granular or vacuolated cytoplasm, occasionally with cross-striations. Immunohistochemically, the cells were positive for desmin, myogenin, Myo-D1, but negative for S-100. Due to these characteristic morphologies, adult rhabdomyoma was diagnosed.
CONCLUSION: This is the first report on an adult rhabdomyoma with a proven rapid enlargement. The possible pathomechanisms are discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15791475     DOI: 10.1007/s10006-005-0608-6

Source DB:  PubMed          Journal:  Mund Kiefer Gesichtschir        ISSN: 1432-9417


  8 in total

1.  Images in cardiology. Enlargement of cardiac rhabdomyoma and myocardial ischaemia during corticotropin treatment for infantile spasm.

Authors:  S Hiraishi; N Iwanami; N Ogawa
Journal:  Heart       Date:  2000-08       Impact factor: 5.994

2.  Glucocorticoid hormone stimulates mitochondrial biogenesis specifically in skeletal muscle.

Authors:  Katharina Weber; Patrick Brück; Zsuzsanna Mikes; Jan-Heiner Küpper; Martin Klingenspor; Rudolf J Wiesner
Journal:  Endocrinology       Date:  2002-01       Impact factor: 4.736

3.  Recurrent rhabdomyosarcoma after 25 years: a possible association with estrogen and progestogen therapy.

Authors:  M Zacharin; K Waters; C W Chow; P Crock; P McKelvie
Journal:  J Pediatr Hematol Oncol       Date:  1997 Sep-Oct       Impact factor: 1.289

4.  Subcellular localization of the steroid receptor coactivators (SRCs) and MEF2 in muscle and rhabdomyosarcoma cells.

Authors:  S L Chen; S C Wang; B Hosking; G E Muscat
Journal:  Mol Endocrinol       Date:  2001-05

Review 5.  Immunochemistry and electron microscopy of head and neck rhabdomyoma.

Authors:  T R Helliwell; M C Sissons; P J Stoney; M T Ashworth
Journal:  J Clin Pathol       Date:  1988-10       Impact factor: 3.411

6.  Metabolic and ultrastructural aspects of the in vitro lysis of chronic lymphocytic leukemia cells by glucocorticoids.

Authors:  U Galili; R Leizerowitz; J Moreb; H Gamliel; D Gurfel; A Polliack
Journal:  Cancer Res       Date:  1982-04       Impact factor: 12.701

7.  Rhabdomyoma of the head and neck: clinicopathologic features of two cases.

Authors:  Gianfranco Favia; Lorenzo Lo Muzio; Rosario Serpico; Eugenio Maiorano
Journal:  Head Neck       Date:  2003-08       Impact factor: 3.147

8.  Adult rhabdomyoma of the head and neck: a clinicopathologic and immunophenotypic study.

Authors:  S B Kapadia; J M Meis; D M Frisman; G L Ellis; D K Heffner; V J Hyams
Journal:  Hum Pathol       Date:  1993-06       Impact factor: 3.466

  8 in total
  2 in total

1.  Rhabdomyoma of the head and neck: morphology and differential diagnosis.

Authors:  Torsten Hansen; Detlef Katenkamp
Journal:  Virchows Arch       Date:  2005-08-18       Impact factor: 4.064

2.  S-100 Immunohistochemical Positivity in Rhabdomyoma: An Underestimated Potential Diagnostic Pitfall in Routine Practice.

Authors:  Andrea Palicelli; Antonio Ramponi; Guido Valente; Renzo Boldorini; Annalisa Balbo Mussetto; Magda Zanelli
Journal:  Diagnostics (Basel)       Date:  2022-04-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.